Blood coagulants

Tender description

NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework is intended for use by: — the Department of Health and Social Care, — Public Health England and the NHS in England, — Scotland, — Wales and Northern Ireland. The framework may also be used by private sector Contractors and agents working on behalf of the above. The framework will commence on 1.3.2019 for a period of 24 months until 28.2.2021, with options to extend for a further 24 months. Please refer to the invitation to offer documents for the list of purchasing points. NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B. The framework is intended for use by: — the Department of Health and Social Care, — Public Health England and the NHS in England, — Scotland, — Wales and Northern Ireland. The framework may also be used by private sector Contractors and agents working on behalf of the above. The framework will commence on 1.3.2019 for a period of 24 months until 28.2.2021, with options to extend for a further 24 months. Please refer to the Invitation to Offer documents for the list of purchasing points.